Park Place Capital Corp Sells 2,995 Shares of Rentokil Initial plc (NYSE:RTO)

Park Place Capital Corp lessened its stake in Rentokil Initial plc (NYSE:RTO) by 38.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,874 shares of the company’s stock after selling 2,995 shares during the period. Park Place Capital Corp’s holdings in Rentokil Initial were worth $147,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Park Avenue Securities LLC raised its position in Rentokil Initial by 15.2% in the 1st quarter. Park Avenue Securities LLC now owns 13,376 shares of the company’s stock worth $403,000 after purchasing an additional 1,764 shares during the last quarter. Gates Capital Management Inc. raised its position in shares of Rentokil Initial by 11.4% during the 4th quarter. Gates Capital Management Inc. now owns 5,155,193 shares of the company’s stock valued at $147,490,000 after acquiring an additional 528,409 shares during the last quarter. Schroder Investment Management Group raised its position in shares of Rentokil Initial by 13.8% during the 4th quarter. Schroder Investment Management Group now owns 2,025,479 shares of the company’s stock valued at $57,949,000 after acquiring an additional 246,253 shares during the last quarter. Marlowe Partners LP bought a new stake in shares of Rentokil Initial during the 4th quarter valued at $586,000. Finally, Exencial Wealth Advisors LLC bought a new stake in shares of Rentokil Initial during the 4th quarter valued at $786,000. Institutional investors own 9.91% of the company’s stock.

Rentokil Initial Price Performance

Shares of RTO traded down $0.19 during trading hours on Monday, reaching $29.46. The stock had a trading volume of 446,012 shares, compared to its average volume of 667,826. Rentokil Initial plc has a 52 week low of $23.39 and a 52 week high of $41.55. The firm has a 50-day moving average of $27.52 and a 200 day moving average of $27.80.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. UBS Group upgraded shares of Rentokil Initial from a “sell” rating to a “neutral” rating in a research report on Monday. BNP Paribas upgraded shares of Rentokil Initial from a “neutral” rating to an “outperform” rating in a research report on Monday, March 18th. Finally, JPMorgan Chase & Co. began coverage on shares of Rentokil Initial in a research report on Tuesday, April 23rd. They issued a “neutral” rating for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Rentokil Initial currently has a consensus rating of “Hold” and an average price target of $29.00.

Rentokil Initial Company Profile

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.